HIV Surveillance Supplemental Report — Volume 28, Number 4

HIV Surveillance Report - Supplemental Report banner

Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data—United States and 6 Dependent Areas, 2021

Key Findings

The Selected National HIV Prevention and Care Outcomes are indicators used to monitor progress toward U.S. national goals outlined in Healthy People 2030, the National HIV/AIDS Strategy, and the Ending the HIV Epidemic in the U.S. (EHE) initiative. Data are presented for diagnoses of HIV infection reported to CDC through December 2022.

Differences in Linkage to Care Among People with Diagnosed HIV by Race and Ethnicity in 47 States and the District of Columbia*†
More than 80% of people overall with HIV diagnosed in 2021 were linked to care within one month of diagnosis.
This chart shows the percentage of people linked to care by race/ethnicity.

* Among people aged 13 and older.
† Linkage to care is defined as at least 1 viral load or CD4 test within one month of HIV diagnosis during 2021.
‡ Hispanic/Latino people can be of any race.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report 2023;28(4).

HIV Care Among People with Diagnosed HIV in 47 States and the District of Columbia*
This chart shows the proportion of people who received care, were retained in care, and were virally suppressed.

* Among people aged 13 and older.
† At least 1 viral load or CD4 test during 2021.
‡ Had 2 viral load or CD4 tests at least 3 months apart during 2021.
** Based on most recent viral load test during 2021.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report 2023;28(4).

Differences in HIV Care Among People with Diagnosed HIV by Race and Ethnicity in 47 States and the District of Columbia*
This chart shows the proportion of people who received care, were retained in care, and were virally suppressed by race/ethnicity.

* Among people aged 13 and older.
† At least 1 viral load or CD4 test during 2021.
‡ Had 2 viral load or CD4 tests at least 3 months apart during 2021.
** Based on most recent viral load test during 2021.
†† Hispanic/Latino people can be of any race.
Source: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report 2023;28(4).

Differences in PrEP Coverage in the United States by Race and Ethnicity*
Of the 1.2 million people in the US and Puerto Rico who could benefit from PrEP, only 30% were prescribed PrEP.
This chart shows the percentage of people who were prescribed PrEP by race/ethnicity.

Abbreviation: PrEP = Pre-exposure prophylaxis.
* Among people aged 16 and older.
† Hispanic/Latino people can be of any race.
‡ Includes American Indian/Alaska Native, Asian, Native Hawaiian and other Pacific Islander, and multiracial people.

The HIV Surveillance Supplemental Report is not copyrighted and may be used and copied without permission. Citation of the source is, however, appreciated.

Suggested Citation

Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report, 2023; 28(No. 4). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published May 2023. Accessed [date].

Confidential Information, Referrals, and Educational Material on HIV Infection

CDC-INFO
1-800-232-4636 (in English, en Español)
1-888-232-6348 (TTY)
http://wwwn.cdc.gov/dcs/ContactUs/Form

Acknowledgments

This report was prepared by the following staff and contractors of the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC: Shacara Johnson Lyons, Juliet Morales, Anna Satcher Johnson, Xiaohong Hu, Pei Hou, Zanetta Gant, Anna D. Baker, André F. Dailey, Amanda Okello, Ya-lin Huang, Weiming Zhu, Lei Yu, Avery Smithson, Wei Wei, Iddrisu Abdallah, Anne Peruski, Michael Friend (editing), Azfar Siddiqi (science review), and Chief of the HIV Surveillance Branch, Angela L. Hernandez.

We also thank the following staff for their contributions to the report: Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC: Norma Harris, Donna McCree, Krishna Kota; the Prevention Communication Branch: Nitesh Parmar, Scott Outman, Kyle Roberts (Web and Consumer Services Team); and the Division of Communication Services: Mikaelyn Benson, Deirdre Launt, Meredith Newlove, Cesar Rivera (Design Team).

Publication of this report would not have been possible without the contributions of the state and territorial health departments and the HIV surveillance programs that provided surveillance data to CDC.